Clinical trial
Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in…
NCT00448799 · Molecular NeuroImaging, Other · Completed
Key facts
| NCT number | NCT00448799 |
|---|---|
| Title | Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls |
| Official title | Evaluation of [123I] AV83 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects |
| Lead sponsor | Molecular NeuroImaging, Other |
| Collaborators | Institute for Neurodegenerative Disorders |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Alzheimers Disease |
| Intervention type | Radiation |
| Interventions | [123-I] AV-83 Injection and Imaging Procedures |
| Enrollment | 30 |
| Start date | Mar 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Mar 19, 2007 |
| Last update posted | May 13, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: